| MeSH term | MeSH ID | Detail |
|---|---|---|
| Edema | D004487 | 152 associated lipids |
| Precancerous Conditions | D011230 | 48 associated lipids |
| Postoperative Complications | D011183 | 5 associated lipids |
| Arthritis | D001168 | 41 associated lipids |
| Arthritis, Experimental | D001169 | 24 associated lipids |
| Surgical Wound Infection | D013530 | 7 associated lipids |
| Neoplasm Recurrence, Local | D009364 | 5 associated lipids |
| Osteonecrosis | D010020 | 5 associated lipids |
| Hypotension | D007022 | 41 associated lipids |
| Acute Kidney Injury | D058186 | 34 associated lipids |
tacrolimus
Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.
Cross Reference
Introduction
To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with tacrolimus?
tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (2)
- Am. J. Physiol. Renal Physiol. (1)
- Drug Metab. Dispos. (1)
- Others (1)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with tacrolimus
PubChem Associated disorders and diseases
What pathways are associated with tacrolimus
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with tacrolimus?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with tacrolimus?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with tacrolimus?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with tacrolimus?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with tacrolimus?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with tacrolimus
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Kamburova EG et al. | Longitudinal analysis of T and B cell phenotype and function in renal transplant recipients with or without rituximab induction therapy. | 2014 | PLoS ONE | pmid:25393622 |
| Jun H et al. | Experiences on conversion to once-daily Advagraf and sirolimus combination in stable kidney recipients. | 2014 | Transplant. Proc. | pmid:24655973 |
| Masutani K et al. | Protocol biopsy findings in living donor kidney transplant patients treated with once-daily or twice-daily tacrolimus formulation. | 2014 | Transplant. Proc. | pmid:24655972 |
| Tian SY et al. | Immunosuppressive therapies for the induction treatment of proliferative lupus nephritis: a systematic review and network metaanalysis. | 2014 | J. Rheumatol. | pmid:25225281 |
| DU C et al. | [In vitro effects of tacrolimus on platelet function]. | 2014 | Zhonghua Xue Ye Xue Za Zhi | pmid:25339327 |
| Verma M et al. | Impact of single immunosuppressive drug withdrawal on lymphocyte immunoreactivity. | 2014 | J. Surg. Res. | pmid:24485875 |
| El-Sheikh AA et al. | Renal glucuronidation and multidrug resistance protein 2-/ multidrug resistance protein 4-mediated efflux of mycophenolic acid: interaction with cyclosporine and tacrolimus. | 2014 | Transl Res | pmid:24486136 |
| Carr L et al. | Calcineurin activity assay measurement by liquid chromatography-tandem mass spectrometry in the multiple reaction monitoring mode. | 2014 | Clin. Chem. | pmid:24281780 |
| Xie M et al. | Tacrolimus-related seizure after pediatric liver transplantation--a single-center experience. | 2014 | Pediatr Transplant | pmid:24283660 |
| Vavic N et al. | The influence of comedication on tacrolimus blood concentration in patients subjected to kidney transplantation: a retrospective study. | 2014 | Eur J Drug Metab Pharmacokinet | pmid:24356808 |
| Chen D et al. | Association of hemoglobin levels, CYP3A5, and NR1I3 gene polymorphisms with tacrolimus pharmacokinetics in liver transplant patients. | 2014 | Drug Metab. Pharmacokinet. | pmid:24351870 |
| Hirai F et al. | Impact of CYP3A5 genetic polymorphisms on the pharmacokinetics and short-term remission in patients with ulcerative colitis treated with tacrolimus. | 2014 | J. Gastroenterol. Hepatol. | pmid:24033383 |
| Shlivko IL et al. | Morphological changes in skin of different phototypes under the action of topical corticosteroid therapy and tacrolimus. | 2014 | Skin Res Technol | pmid:23808907 |
| Jacobo-Cabral CO et al. | Limustin®, a non-innovator tacrolimus formulation, yields reduced drug exposure in pediatric renal transplant recipients. | 2014 | Pediatr Transplant | pmid:25156476 |
| Werk AN et al. | Identification and characterization of a defective CYP3A4 genotype in a kidney transplant patient with severely diminished tacrolimus clearance. | 2014 | Clin. Pharmacol. Ther. | pmid:24126681 |
| Carcas-Sansuán AJ et al. | Conversion from Prograf to Advagraf in stable paediatric renal transplant patients and 1-year follow-up. | 2014 | Pediatr. Nephrol. | pmid:23907143 |
| Tolar J and McGrath JA | Augmentation of cutaneous wound healing by pharmacologic mobilization of endogenous bone marrow stem cells. | 2014 | J. Invest. Dermatol. | pmid:25120149 |
| ZivÄić-Ćosić S et al. | Immune reactivity of renal transplant recipients receiving interleukin-2 receptor antagonists during the early posttransplant period. | 2014 | Int Urol Nephrol | pmid:23515930 |
| Hadjipanagi D et al. | Genetic polymorphisms in warfarin and tacrolimus-related genes VKORC1, CYP2C9 and CYP3A5 in the Greek-Cypriot population. | 2014 | BMC Res Notes | pmid:24593903 |
| Li Q et al. | Proniosome-derived niosomes for tacrolimus topical ocular delivery: in vitro cornea permeation, ocular irritation, and in vivo anti-allograft rejection. | 2014 | Eur J Pharm Sci | pmid:24905830 |
| Oda K and Yamano K | Effect of telaprevir on the metabolism and hepatic uptake of tacrolimus (FK506). | 2014 | Biopharm Drug Dispos | pmid:25059890 |
| Lapteva M et al. | Polymeric micelle nanocarriers for the cutaneous delivery of tacrolimus: a targeted approach for the treatment of psoriasis. | 2014 | Mol. Pharm. | pmid:25057896 |
| Shilpa PS et al. | Topical tacrolimus in the management of oral lichen planus: literature review. | 2014 | J Calif Dent Assoc | pmid:25080722 |
| Kassir N et al. | Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in paediatric liver transplant recipients. | 2014 | Br J Clin Pharmacol | pmid:24977292 |
| Nath PR et al. | Immunophilins control T lymphocyte adhesion and migration by regulating CrkII binding to C3G. | 2014 | J. Immunol. | pmid:25225668 |
| Buechter M et al. | Tacrolimus as a reasonable alternative in a patient with steroid-dependent and thiopurine-refractory autoimmune pancreatitis with IgG4-associated cholangitis. | 2014 | Z Gastroenterol | pmid:24905108 |
| Kurbalija V et al. | Time-series analysis in the medical domain: a study of Tacrolimus administration and influence on kidney graft function. | 2014 | Comput. Biol. Med. | pmid:24813681 |
| Dipchand AI et al. | Myocyte growth, repair, and oxidative stress following pediatric heart transplantation. | 2014 | Pediatr Transplant | pmid:25118092 |
| Hošková L et al. | Tacrolimus-induced hypertension and nephrotoxicity in Fawn-Hooded rats are attenuated by dual inhibition of renin-angiotensin system. | 2014 | Hypertens. Res. | pmid:24718302 |
| Fernandes MB et al. | Supplementation with omega-3 polyunsaturated fatty acids and experimental tacrolimus-induced nephrotoxicity. | 2014 | Exp Clin Transplant | pmid:25489802 |
| Larkins N and Matsell DG | Tacrolimus therapeutic drug monitoring and pediatric renal transplant graft outcomes. | 2014 | Pediatr Transplant | pmid:25284168 |
| Heilman RL et al. | Delayed allograft inflammation following alemtuzumab induction for kidney transplantation. | 2013 Sep-Oct | Clin Transplant | pmid:23924146 |
| Benoit S and Hamm H | Psoriasis from a prosthesis: unusual Koebner phenomenon in a girl with autoamputation of the leg. | 2013 Sep-Oct | Pediatr Dermatol | pmid:23360396 |
| Zahdi MR et al. | Erosive pustular dermatosis of the scalp successfully treated with oral prednisone and topical tacrolimus. | 2013 Sep-Oct | An Bras Dermatol | pmid:24173187 |
| Riva N et al. | [Pharmacovigilance of calcineurin inhibitor in peidatric kidney and liver transplantation]. | 2013 Nov-Dec | Farm Hosp | pmid:24256007 |
| Brodrick B et al. | Influence of treatments on prognosis for vulvar lichen sclerosus: facts and controversies. | 2013 Nov-Dec | Clin. Dermatol. | pmid:24160287 |
| Bloom RD et al. | A randomized, crossover pharmacokinetic study comparing generic tacrolimus vs. the reference formulation in subpopulations of kidney transplant patients. | 2013 Nov-Dec | Clin Transplant | pmid:24118450 |
| Labirua-Iturburu A et al. | Calcineurin inhibitors in a cohort of patients with antisynthetase-associated interstitial lung disease. | 2013 May-Jun | Clin. Exp. Rheumatol. | pmid:23465087 |
| Chen SY et al. | Individualization of tacrolimus dosage basing on cytochrome P450 3A5 polymorphism--a prospective, randomized, controlled study. | 2013 May-Jun | Clin Transplant | pmid:23432535 |
| Ramirez CB et al. | Completely steroid-free immunosuppression in liver transplantation: a randomized study. | 2013 May-Jun | Clin Transplant | pmid:23621629 |
| Krishna N et al. | Tacrolimus-induced paranoid delusions and fugue-like state. | 2013 May-Jun | Gen Hosp Psychiatry | pmid:22959421 |
| He L et al. | Treatment of idiopathic membranous nephropathy with combination of low-dose tacrolimus and corticosteroids. | 2013 May-Jun | J. Nephrol. | pmid:22956434 |
| Kanzelmeyer NK et al. | Correlations with six-month protocol biopsy findings in pediatric transplant recipients on low- and regular-dose CNI regimens. | 2013 Mar-Apr | Clin Transplant | pmid:23414365 |
| Tiwari R et al. | Enhancements in healthcare information technology systems: customizing vendor-supplied clinical decision support for a high-risk patient population. | 2013 Mar-Apr | J Am Med Inform Assoc | pmid:22813760 |
| Albekairy A et al. | Cytochrome P450 3A4FNx011B as pharmacogenomic predictor of tacrolimus pharmacokinetics and clinical outcome in the liver transplant recipients. | 2013 Mar-Apr | Saudi J Gastroenterol | pmid:23481136 |
| LaMattina JC et al. | Native kidney function following liver transplantation using calcineurin inhibitors: single-center analysis with 20 years of follow-up. | 2013 Mar-Apr | Clin Transplant | pmid:23294013 |
| Alfson ED et al. | Lysis of catatonic withdrawal by propofol in a bone-marrow transplant recipient with adenovirus limbic encephalitis. | 2013 Mar-Apr | Psychosomatics | pmid:22705183 |
| Yoshida EM et al. | Canadian national retrospective chart review comparing the long term effect of cyclosporine vs. tacrolimus on clinical outcomes in patients with post-liver transplantation hepatitis C virus infection. | 2013 Mar-Apr | Ann Hepatol | pmid:23396740 |
| Castillo G et al. | [Acute cellular rejection in a liver transplantation patient due to changing the brand of a generic immunosuppressant]. | 2013 Jul-Sep | Rev Gastroenterol Mex | pmid:23866966 |
| Bechstein WO et al. | A comparative, randomized trial of concentration-controlled sirolimus combined with reduced-dose tacrolimus or standard-dose tacrolimus in renal allograft recipients. | 2013 Jul-Aug | Transplant. Proc. | pmid:23953523 |
| Zhao YJ et al. | Late, severe, noninfectious diarrhea after renal transplantation: high-risk factors, therapy, and prognosis. | 2013 Jul-Aug | Transplant. Proc. | pmid:23953533 |
| Weiler N et al. | Tacrolimus effects and side effects after liver transplantation: is there a difference between immediate and extended release? | 2013 Jul-Aug | Transplant. Proc. | pmid:23953543 |
| Stringa P et al. | Ischemic preconditioning and tacrolimus pretreatment as strategies to attenuate intestinal ischemia-reperfusion injury in mice. | 2013 Jul-Aug | Transplant. Proc. | pmid:23953566 |
| Tachibana A et al. | Repopulation of the immunosuppressed retrorsine-treated infant rat liver with human hepatocytes. | 2013 Jul-Aug | Xenotransplantation | pmid:23683097 |
| Favi E et al. | Tacrolimus plus mycophenolate mofetil vs. cyclosporine plus everolimus in deceased donor kidney transplant recipients: three-yr results of a single-center prospective clinical trial. | 2013 Jul-Aug | Clin Transplant | pmid:23710603 |
| Eberlin M et al. | Increased medication compliance of liver transplant patients switched from a twice-daily to a once-daily tacrolimus-based immunosuppressive regimen. | 2013 Jul-Aug | Transplant. Proc. | pmid:23726723 |
| Satyanarayan HS et al. | Efficacy and tolerability of combined treatment with NB-UVB and topical tacrolimus versus NB-UVB alone in patients with vitiligo vulgaris: a randomized intra-individual open comparative trial. | 2013 Jul-Aug | Indian J Dermatol Venereol Leprol | pmid:23760325 |
| Babalola O and Strober BE | Treatment of atopic dermatitis in pregnancy. | 2013 Jul-Aug | Dermatol Ther | pmid:23914886 |
| Conti R et al. | Jessner-Kanof disease: two effective and sure therapeutic options. | 2013 Jul-Aug | Dermatol Ther | pmid:23914897 |
| Chakkera HA et al. | Genetic differences in Native Americans and tacrolimus dosing after kidney transplantation. | 2013 Jan-Feb | Transplant. Proc. | pmid:23375287 |
| Tian Ch et al. | B- and T-lymphocyte attenuator/herpes virus entry mediator as early indicators for acute rejection following kidney transplantation. | 2013 Jan-Feb | Transplant. Proc. | pmid:23375291 |
| Yao B et al. | The incidence of posttransplantation diabetes mellitus during follow-up in kidney transplant recipients and relationship to Fok1 vitamin D receptor polymorphism. | 2013 Jan-Feb | Transplant. Proc. | pmid:23375298 |
| Miyazaki T et al. | Two case reports of successful withdrawal of mycofenolate mofetil after living donor lobar lung transplantation. | 2013 Jan-Feb | Transplant. Proc. | pmid:23375323 |
| Chang HY et al. | Long-term follow-up of arrhythmia characteristics and clinical outcomes in heart transplant patients. | 2013 Jan-Feb | Transplant. Proc. | pmid:23375324 |
| Al Nahdi N et al. | First successful treatment of post-liver transplant hepatitis C fibrosing cholestatic hepatitis with boceprevir, peginterferon and ribavirin in a pre-transplant null responder. | 2013 Jan-Feb | Ann Hepatol | pmid:23293209 |
| Seco-Melantuche R et al. | [Incidence of drug-induced thrombocytopenia in hospitalized patients]. | 2013 Jan-Feb | Farm Hosp | pmid:23461497 |
| Rao V et al. | A non-induction renal sparing approach after liver transplantation: high dose mycophenolate mofetil with delayed, low-dose tacrolimus. | 2013 Jan-Feb | Transplant. Proc. | pmid:23267806 |
| Langone A et al. | Does reduction in mycophenolic acid dose compromise efficacy regardless of tacrolimus exposure level? An analysis of prospective data from the Mycophenolic Renal Transplant (MORE) Registry. | 2013 Jan-Feb | Clin Transplant | pmid:22861144 |
| Shiba H et al. | Switching from tacrolimus to cyclosporine A to prevent primary biliary cirrhosis recurrence after living-donor liver transplantation. | 2013 Apr-Jun | Int Surg | pmid:23701152 |
| Adamu B et al. | New-onset diabetes after renal transplantation: a case series as seen in a Nigerian kidney transplant population. | 2013 Apr-Jun | Niger J Clin Pract | pmid:23563475 |
| Cangemi G et al. | Comparison of antibody-conjugated magnetic immunoassay and liquid chromatography-tandem mass spectrometry for the measurement of cyclosporine and tacrolimus in whole blood. | 2013 Apr-Jun | Int J Immunopathol Pharmacol | pmid:23755756 |
| Ogasawara K et al. | Multidrug resistance-associated protein 2 (MRP2/ABCC2) haplotypes significantly affect the pharmacokinetics of tacrolimus in kidney transplant recipients. | 2013 | Clin Pharmacokinet | pmid:23633119 |
| Yagi Y et al. | Tacrolimus monotherapy: a promising option for ocular myasthenia gravis. | 2013 | Eur. Neurol. | pmid:23549260 |
| Morgan RE et al. | A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. | 2013 | Toxicol. Sci. | pmid:23956101 |
| Liu F et al. | FK506-binding protein 12 ligands: a patent review. | 2013 | Expert Opin Ther Pat | pmid:23957229 |
| de Jonge H and Kuypers DR | Response to "pretransplantation pharmacokinetic assessments to predict posttransplantation dosing requirements in renal transplant recipients: what is known?". | 2013 | Clin. Pharmacol. Ther. | pmid:23340478 |
| Risseeuw MD et al. | A "clickable" MTX reagent as a practical tool for profiling small-molecule-intracellular target interactions via MASPIT. | 2013 | ChemMedChem | pmid:23341183 |
| Takahara S et al. | Randomized comparative trial of mizoribine versus mycophenolate mofetil in combination with tacrolimus for living donor renal transplantation. | 2013 | Clin. Exp. Nephrol. | pmid:23430390 |
| Sugiura K et al. | Cutaneous lupus mucinosis successfully treated with systemic corticosteroid and systemic tacrolimus combination therapy. | 2013 | J. Am. Acad. Dermatol. | pmid:24034403 |
| Verhave JC et al. | Living kidney transplantation in adult patients with atypical haemolytic uraemic syndrome. | 2013 | Neth J Med | pmid:24038559 |
| Wu X et al. | Design and physicochemical characterization of advanced spray-dried tacrolimus multifunctional particles for inhalation. | 2013 | Drug Des Devel Ther | pmid:23403805 |
| Lee Y et al. | Long-term follow-up of de novo allergy in pediatric liver transplantation--10 yr experience of a single center. | 2013 | Pediatr Transplant | pmid:23405954 |
| Manthripragada AD et al. | Off-label topical calcineurin inhibitor use in children. | 2013 | Pediatrics | pmid:24127469 |
| Almazrooa SA et al. | Characterization and management of exfoliative cheilitis: a single-center experience. | 2013 | Oral Surg Oral Med Oral Pathol Oral Radiol | pmid:24237731 |
| Sy SK et al. | A Markov chain model to evaluate the effect of CYP3A5 and ABCB1 polymorphisms on adverse events associated with tacrolimus in pediatric renal transplantation. | 2013 | AAPS J | pmid:23990505 |
| Sun W et al. | Rapid identification of antifungal compounds against Exserohilum rostratum using high throughput drug repurposing screens. | 2013 | PLoS ONE | pmid:23990907 |
| Tortorici MA et al. | The evaluation of potential pharmacokinetic interaction between sirolimus and tacrolimus in healthy volunteers. | 2013 | Eur. J. Clin. Pharmacol. | pmid:23052408 |
| Chisholm-Burns MA et al. | Improving outcomes of renal transplant recipients with behavioral adherence contracts: a randomized controlled trial. | 2013 | Am. J. Transplant. | pmid:23819827 |
| Sen A et al. | Acute brachial neuritis with central pontine and extrapontine myelinolysis in a renal transplant recipient. | 2013 | Neurol. Sci. | pmid:23820960 |
| Yoshimura K et al. | Successful treatment with 308-nm monochromatic excimer light and subsequent tacrolimus 0.03% ointment in refractory plasma cell cheilitis. | 2013 | J. Dermatol. | pmid:23621817 |
| Kang KY et al. | Tacrolimus treatment increases bone formation in patients with rheumatoid arthritis. | 2013 | Rheumatol. Int. | pmid:22447331 |
| Gerich ME et al. | Tacrolimus salvage in anti-tumor necrosis factor antibody treatment-refractory Crohn's disease. | 2013 | Inflamm. Bowel Dis. | pmid:23518805 |
| Monroe JR | Progressive changes in facial pigmentation. | 2013 | JAAPA | pmid:23520799 |
| von Suesskind-Schwendi M et al. | Pharmacokinetics of a self-microemulsifying drug delivery system of tacrolimus. | 2013 | Biomed. Pharmacother. | pmid:23669280 |
| Rath T | Tacrolimus in transplant rejection. | 2013 | Expert Opin Pharmacother | pmid:23228138 |
| Renner FC et al. | The risk of polyomavirus-associated graft nephropathy is increased by a combined suppression of CD8 and CD4 cell-dependent immune effects. | 2013 | Transplant. Proc. | pmid:23726630 |
| Uni M et al. | Successful allogeneic stem cell transplantation for Lennert lymphoma. | 2013 | Ann. Hematol. | pmid:23224245 |
| Mattox AR et al. | New-onset vitiligo during long-term, stable infliximab treatment of pityriasis rubra pilaris. | 2013 | J Drugs Dermatol | pmid:23377397 |
| Elens L et al. | The CYP3A4*22 allele affects the predictive value of a pharmacogenetic algorithm predicting tacrolimus predose concentrations. | 2013 | Br J Clin Pharmacol | pmid:23163400 |
| Qin XL et al. | Effect of long-term co-administration of Wuzhi tablet (Schisandra sphenanthera extract) and prednisone on the pharmacokinetics of tacrolimus. | 2013 | Phytomedicine | pmid:23267661 |